Apostolaki Maria, Armaka Maria, Victoratos Panayiotis, Kollias George
Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, 34 Al. Fleming Street, Vari, Greece.
Curr Dir Autoimmun. 2010;11:1-26. doi: 10.1159/000289195. Epub 2010 Feb 18.
The TNF/TNF receptor (TNFR) system has a prominent role in the pathogenesis of chronic inflammatory and autoimmune disorders. Extensive research in animal models with deregulated TNF expression has documented that TNF may initiate or sustain inflammatory pathology, while at the same time may exert immunomodulatory or disease-suppressive activities. The TNF/TNFR system encompassing both the soluble and the transmembrane form of TNF with differential biological activities, as well as the differential usage of its receptors, mediating distinct functions, appears to confer complexity but also specificity in the action of TNF. The inherent complexity in TNF-mediated pathophysiology highlights the requirement to address the role of TNF taking into account both proinflammatory tissue-damaging and immunomodulatory functions in a cellular and receptor-specific manner. In this review, we discuss our current understanding of the involvement of TNF in chronic inflammation and autoimmunity, focusing on TNF-mediated cellular pathways leading to the pathogenesis or progression of joint and intestinal inflammatory pathology. Knowledge of the mechanisms by which TNF either initiates or contributes to disease pathology is fundamentally required for the design of safe and effective anti-TNF/TNFR therapies for human inflammatory and autoimmune disorders.
肿瘤坏死因子/肿瘤坏死因子受体(TNFR)系统在慢性炎症和自身免疫性疾病的发病机制中起着重要作用。对肿瘤坏死因子表达失调的动物模型进行的广泛研究表明,肿瘤坏死因子可能引发或维持炎症病理,同时可能发挥免疫调节或疾病抑制活性。肿瘤坏死因子/TNFR系统包括具有不同生物学活性的可溶性和跨膜形式的肿瘤坏死因子,以及其受体的不同用途,介导不同的功能,这似乎赋予了肿瘤坏死因子作用的复杂性和特异性。肿瘤坏死因子介导的病理生理学的内在复杂性突出了以细胞和受体特异性方式考虑肿瘤坏死因子的促炎组织损伤和免疫调节功能来研究其作用的必要性。在这篇综述中,我们讨论了目前对肿瘤坏死因子参与慢性炎症和自身免疫的理解,重点关注肿瘤坏死因子介导的导致关节和肠道炎症病理发生或进展的细胞途径。对于设计用于治疗人类炎症和自身免疫性疾病的安全有效的抗肿瘤坏死因子/TNFR疗法来说,从根本上需要了解肿瘤坏死因子引发或促成疾病病理的机制。